SOL Capital Management CO Lowers Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SOL Capital Management CO cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 30,042 shares of the exchange traded fund’s stock after selling 842 shares during the period. SOL Capital Management CO’s holdings in SPDR S&P Biotech ETF were worth $2,436,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Demars Financial Group LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $280,309,000. BlueCrest Capital Management Ltd purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $138,051,000. Mirae Asset Securities USA Inc. boosted its holdings in SPDR S&P Biotech ETF by 66.7% during the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after buying an additional 600,000 shares in the last quarter. Bessemer Group Inc. boosted its holdings in SPDR S&P Biotech ETF by 4.0% during the first quarter. Bessemer Group Inc. now owns 1,432,066 shares of the exchange traded fund’s stock worth $116,141,000 after buying an additional 55,232 shares in the last quarter. Finally, RA Capital Management L.P. purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $110,615,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $83.27 on Thursday. The company’s fifty day moving average price is $80.64 and its 200 day moving average price is $85.41. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47. The company has a market capitalization of $4.48 billion, a PE ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.